Connor Clark and Lunn Investment Management Ltd. bought a new stake in shares of CVS Health Corporation (NYSE: CVS) during the second quarter, according to its most recent 13F filing with the SEC. The
Insights from Glenview Capital Management's Third Quarter 2025 13F Filing Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the third qua
Exploring the Latest 13F Filing for Q3 2025 HOTCHKIS and WILEY (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2025, providing ins
Exploring the Strategic Moves in Hillman Capital Management's Latest 13F Filing Mark Hillman (Trades, Portfolio) recently submitted the 13F filing for the thir
Exploring the Latest 13F Filing and Investment Adjustments Prem Watsa (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2025, prov
Allworth Financial LP increased its position in shares of CVS Health Corporation (NYSE: CVS) by 3.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the
Advisors Capital Management LLC increased its holdings in CVS Health Corporation (NYSE: CVS) by 4.7% in the undefined quarter, according to the company in its most recent Form 13F filing with the Secu
Insightful Analysis of Dodge and Cox's Third Quarter 2025 13F Filing Dodge and Cox recently submitted their 13F filing for the third quarter of 2025, offering a gl
CVS Health is successfully navigating industrywide and company-specific headwinds while maintaining a solid dividend program. Johnson & Johnson's rock-solid balance sheet and ability to develop brand-

3 Stocks That Have Made Epic Comebacks in 2025

09:37am, Wednesday, 12'th Nov 2025
These three stocks all looked down and out toward the end of 2024. Through the first 10 months of 2025, however, they were all up more than 70%.
Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in favor of a rival medication from Novo Nordisk , Bloomberg News reported on Tue
CVS raises its full-year EPS outlook after a strong quarter, driven by gains across all segments and solid pharmacy growth.
Current CVS Health CEO David Joyner took over a little over a year ago. The company's growth rate has been improving and its overall financial results have been stronger.
Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).
WOONSOCKET, R.I. , Nov. 10, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold its Investor Day on December 9 th, 2025.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE